|
SFT2D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85460999999609E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.231700E-04 |
| Normal-vs-Stage2 |
1.185600E-04 |
| Normal-vs-Stage3 |
3.5819000000048E-05 |
| Normal-vs-Stage4 |
3.036200E-04 |
| Stage1-vs-Stage2 |
4.591900E-02 |
| Stage1-vs-Stage3 |
1.263580E-01 |
| Stage1-vs-Stage4 |
2.571800E-01 |
| Stage2-vs-Stage3 |
3.979200E-01 |
| Stage2-vs-Stage4 |
4.345800E-01 |
| Stage3-vs-Stage4 |
9.763200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.35949999996643E-06 |
| Normal-vs-AfricanAmerican |
1.172160E-01 |
| Normal-vs-Asian |
1.459580E-01 |
| Caucasian-vs-AfricanAmerican |
2.567000E-01 |
| Caucasian-vs-Asian |
7.965900E-02 |
| AfricanAmerican-vs-Asian |
8.670200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.26589999996474E-06 |
| Normal-vs-Female |
1.442660E-04 |
| Male-vs-Female |
8.994400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.803000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.440700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.1654000004776E-07 |
| Normal-vs-Age(81-100Yrs) |
1.235960E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.407600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.899740E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.173000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.481700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.480000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.992000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.414800E-01 |
| Classical-VS-Follicular |
1.344040E-01 |
| Classical-VS-Other |
3.283400E-01 |
| Classical-VS-Normal |
7.044100E-04 |
| Tall-VS-Follicular |
9.452000E-01 |
| Tall-VS-Other |
7.158200E-01 |
| Tall-VS-Normal |
6.433300E-04 |
| Follicular-VS-Other |
8.031800E-01 |
| Follicular-VS-Normal |
3.233100E-04 |
| Other-VS-Normal |
1.391990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.76300000000107E-05 |
| Normal-vs-N1 |
2.14879999999029E-05 |
| N0-vs-N1 |
2.364800E-01 |
|
|
